Organon (OGN) Receivables (2020 - 2026)

Organon has reported Receivables for 7 years, with the latest figure at $1.5 billion in Q2 2026.

• On a quarterly basis, Receivables rose 0.54% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 0.54% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 1.99% from the prior year.
• Receivables was $1.5 billion for Q2 2026 at Organon, up from $1.4 billion in the prior quarter.
• The five-year high for Receivables was $1.9 billion in Q2 2022, with the low at $1.3 billion in Q4 2025.
• Average Receivables over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2023.
• The largest YoY upside for Receivables was 66.34% in 2022 against a maximum downside of 23.22% in 2022.
• Over 5 years, Receivables stood at $1.8 billion in 2022, then fell by 5.68% to $1.7 billion in 2023, then decreased by 22.13% to $1.4 billion in 2024, then decreased by 1.99% to $1.3 billion in 2025, then advanced by 12.1% to $1.5 billion in 2026.
• The last three Receivables figures came in at $1.5 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.